Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of topical M118103 (heparinoid) in steroid-refractory nodular prurigo
jRCT2080223825Phase 2Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Feb 2018
- Countries
- 1
01
Overview
Phase 2 trial of mucopolysaccharide polysulphate in prurigo nodularis (PN) (2 arms), sponsored by Maruho Co., Ltd. Started Feb 2018; status: completed.
02
Drugs
mucopolysaccharide polysulphate
03
Conditions
prurigo nodularis (PN)
Beyond the preview
Go deeper on jRCT2080223825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223825.